The study investigates the properties and applications of a novel strain of Lacticaseibacillus casei LC15 with significant immune-modulating and antimicrobial activities.

The present study introduces a composite probiotic blend comprising Bifidobacterium animalis subsp. lactis BLa36 and Bifidobacterium breve BBr60. This blend demonstrates synergistic effects in stabilizing mood by balancing neurotransmitters, reducing stress responses, and improving behavioral symptoms.

A newly discovered strain of Lactiplantibacillus plantarum Lp18 (CCTCC No: M 20231524), demonstrates significant potential in alleviating constipation and regulating the gut microbiota. This strain exhibits excellent survival in acidic and bile environments, broad-spectrum antibacterial properties, and significant efficacy in enhancing bowel movements.

The development of effective probiotics to enhance immune function is an area of growing interest in both scientific research and practical application. This journal entry details the innovative approach taken to create a composite probiotic product aimed at improving immune responses.

This invention relates to a composite probiotic designed to enhance the absorption of iron ions in the intestines and its various applications. The composite probiotic comprises Lactobacillus gasseri LG08 (CGMCC No. 16131) and Lactobacillus johnsonii LJ09 (CGMCC No. 20123).

The invention relates to a probiotic agent for degrading ethanol, including Lacticaseibacillus rhamnosus LRa66 and Lactiplantibacillus plantarum Lp90. These strains work synergistically to enhance ethanol degradation and alleviate alcohol-induced liver damage.